Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-22

FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Genus Lifesciences Inc.)

View source ↗

Summary

FDA approved a supplemental application for Hydrocodone Bitartrate and Acetaminophen from Genus Lifesciences Inc., enabling its marketing as a generic opioid/ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCODONE BITARTRATE AND ACETAMINOPHEN (Hydrocodone bitartrate and acetaminophen)

Snippet

SUPPL AP for HYDROCODONE BITARTRATE AND ACETAMINOPHEN (HYDROCODONE BITARTRATE AND ACETAMINOPHEN)